Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 776 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
14 Мб
Скачать
10
https://t.me/medicina_free
1 Nail Disorders oftheLower Extremity
Dermatoscopy can aid in recognition with diagnosis con­rmed histopathologically. First line treatment is injection of triamcinolone acetonide [30]. Additional therapies include intramuscular steroids and oral retinoids.
Intralesional and intramuscular corticosteroids are rst line therapy. Additional therapeutic options include tacroli­mus, pimecrolimus, cyclosporine, and retinoids (Fig.1.20) [30].
Fig. 1.19 Nail psoriasis showing nail dystrophy and periungual erythema
1.7 Infections oftheNail Unit
1.7.1 Herpes Simplex (Herpetic Whitlow)
Herpetic whitlow is a blistering infection of a digit caused by the herpes simplex virus [31]. It most commonly occurs in chil­dren and has been reported in ungloved health care workers and contact sport athletes. The condition manifests as painful vesi­cles swelling, and erythema of the distal phalangeal area. This may be preceded by burning, pruritis, and/or tingling in the affected nger. Vesicles may coalesce and lead to a supercial ulceration. The diagnosis is usually made clinically and can be conrmed by culture, PCR testing, or Tzanck smear [32].
Herpetic whitlow usually involves a nger, but involve­ment of a toe has been reported [32]. The condition is self­limiting with resolution of symptoms occurring in 7–10days. Antiviral therapy may shorten the duration of symptoms. Recurrence may be precipitated by fever, sun exposure, or stress (Fig.1.21).
1.7.2 Periungual Viral Warts
Viral warts, or verrucae, are caused by human papilloma­virus (HPV), a double-stranded DNA virus that infects the epidermis. When presenting in and/or around the nail unit, it is referred to as a periungual wart. A periun­gual wart may be present underneath the nail plate in the nail bed or on the lateral or proximal nail folds. Lack of skin lines, hyperkeratosis, and small pinpoint black dots
Fig. 1.20 Nail lichen planus with pterygium formation on great toenail Fig. 1.21 Herpetic whitlow of the hallux
1.8 Tumors oftheNails
https://t.me/medicina_free
Fig. 1.22 Periungual verruca on second digit following cauterization
11
(thrombosed capillaries) are seen throughout the lesion (Fig.1.22) [33].
1.7.3 Onychomycosis
Onychomycosis is a dermatophyte or supercial fungal infec­tion of the nail unit. The condition represents about half of toe­nail pathologies [34]. Onychomycosis or tinea unguium is caused by invasion of the nail unit by dermatophytes, non­dermatophyte molds, and/or Candida albicans. Infected nails are described as onycholytic, discolored, and hyperkeratotic with subungual debris. Clinicians may encounter concomitant tinea pedis or tinea cruris in patients with onychomycosis. Onychomycosis is more common in toenails. Fingernail ony­chomycosis is much less frequent than toenail onychomycosis.
Several subtypes of onychomycosis have been described:
1. Distal (or distal lateral) subungual onychomycosis: This is the most common type in adults and children. It pres­ents as onycholysis with discoloration, subungual debris, and hyperkeratosis. Concurrent tinea pedis is often seen interdigitally or plantarly on the foot. Trichophyton rubrum is the most common pathogen.
2. Proximal subungual onychomycosis: This most com­monly presents in immunocompromised patients as a leukonychia or white discoloration of the proximal nail plate. Distal subungual debris is lacking. Trichophyton rubrum and non-dermatophyte molds are the common pathogens.
Fig. 1.23 Distal subungual onychomycosis of bilateral great toenails
3. Candidal onychomycosis: Onychomycosis caused by Candida occurs most frequently in patients with chronic mucocutaneous candidiasis. The nail can present with onycholysis and paronychia.
4. Supercial white onychomycosis: The white powdery material that accompanies this type of onychomycosis is present on the dorsal aspect of the nail plate. The condition occurs in tropical climates and it is typically caused by Trichophyton mentagrophytes or non-derma­tophyte molds. Clinicians may mistakenly identify proximal subungual onychomycosis as supercial white onychomycosis in very young children due to their thin nail plates.
Oral or topical antifungal medications are used to treat onychomycosis. Consideration should be given to environ­mental factors such as socks, shoe gear, and living quarters (Fig.1.23).
1.8 Tumors oftheNails
1.8.1 Pyogenic Granuloma
Pyogenic granuloma is a benign vascular tumor commonly found within the lateral nail sulcus of the nail bed of the great toe and ngers. Lesions typically present as a pain-
12
https://t.me/medicina_free
Fig. 1.24 Pyogenic granulomas are friable skin lesions that frequently bleed
1 Nail Disorders oftheLower Extremity
Fig. 1.26 Myxoid cyst creating pressure on nail matrix of second nail and leaving a depression
subtypes include dermatobromas, acquired periungual bro­keratomas, and Koenen tumors [3638]. Dermatobromas are pea-shaped growths that may develop spontaneously or after trauma. Acquired periungual brokeratomas are small, asymp­tomatic eshy growths with a keratotic distal tip that usually arise following local trauma. Koenen tumors (periungual bromas) arise in 50% of patients with tuberous sclerosis dur­ing childhood or adolescence and occur more commonly on the toenails. Koenen tumors may present as multiple digitated growths that can produce a longitudinal groove in the nail plate due to matrix compression (Fig.1.25).
Fig. 1.25 Periungual broma on top of hallux nail plate
less erythematous mass [35]. The name is a misnomer as lesions are not associated with purulence or granuloma­tous changes. Lesions may be induced by trauma and less frequently by hormonal changes associated with preg­nancy or medications including oral retinoids. Surgical excision, curettage with cautery, and ablative lasers are therapeutic options (Fig.1.24).
1.8.2 Fibroma/Fibrokeratoma
These are benign tumors of connective tissue that can origi­nate in the nail matrix or within the nail bed and folds. True bromas develop as painless slow growing benign nodular tumors that are rm or elastic in consistency. Nail broma
1.8.3 Myxoid Cyst (Mucoid Cyst)
A mucoid cyst is a benign growth in which the synovium herniates through the joint capsule. The lesion presents as a solitary, non-moveable, smooth-surfaced papule, or nodule localized to the lateral or dorsal aspects of the distal inter­phalangeal joint. Viscous, jelly-like uid ows when punc­tured. It commonly involves the middle or index ngers of the dominant hand and can affect the toes. A traumatic event may trigger it, and the condition is often found in association with osteoarthritis of the underlying joint. Histologically they appear like ganglia with a stalk leading from the joint capsule but they lack a true epithelial lining, making them a pseudocyst. The cyst is xed to the skin, grows slowly, and contains a viscous yellowish uid. Some cysts resolve spon­taneously [39]. Treatment options include surgery, needling and drainage, sclerosant or steroid injection, and cryother­apy. Recurrence rates are variable (Fig.1.26) [40].
1.8 Tumors oftheNails
https://t.me/medicina_free
13
Fig. 1.28 Nail matrix nevi in a child as viewed with a dermatoscope
Fig. 1.27 Exostosis of distal phalanx after hallux toenail removed
in OR
1.8.4 Subungual Exostosis
Subungual exostosis is an uncommon benign osseocartilagi­nous tumor affecting the distal phalanx of the ngers and toes that most commonly affects the hallux. It is character­ized by a cartilaginous cap composed of brocartilage and bone [41]. Lesions most commonly affect persons under the age of 18 with an equal male-to-female ratio and are associ­ated with a history of pain, erythema, and deformity of the nail bed progressing over several months [42]. Diagnosis is made by radiographically. Precipitating factors include infection, trauma, tumor, hereditary abnormality, and activa­tion of a cartilaginous cyst. Marginal surgical excision with minimal trauma to the nail bed is the treatment of choice (Fig.1.27) [43].
1.8.5 Nail Matrix Nevi
Nail matrix nevi presents as a pigmented longitudinal streak within the nail plate. Nail matrix nevi, a benign manifesta­tion of longitudinal melanonychia, occurs more commonly in dark-skinned individuals and can occur in individuals of all ages, with no sex predilection [44]. Dermoscopy may aid in recognition although a punch biopsy is required to deni­tively differentiate between benign nail matrix nevus from subungual melanoma. Pigmentation occurs when melanin is
deposited in the nail matrix by melanocytes. As the nail con­tinues to grow and melanocytes continue to deposit melanin, a longitudinal streak occurs in the nail plate [15]. Melanin deposition in a benign nevus occurs by melanocytic hyper­plasia, which is an increase in the number of melanocytes within the nail matrix itself, rather than an increase in amount of melanin produced by the melanocytes. True nevi are not typically caused by trauma, fungal infection, or systemic dis­ease. Nail matrix nevi are considered benign, and no further treatment is necessary once a denitive diagnosis is made (Fig.1.28).
1.8.6 Bowen’s Disease andSquamous Cell
Carcinoma
Subungual squamous cell carcinoma (SCC) is a malignancy that can occur in any digit but is more common in ngers than in toes. Subungual SCC is a rare entity but is the most common malignancy of the nail bed. The neoplasm can arise from the nail matrix, the nail bed, the nail groove, or the lat­eral nail folds. The great toe is most frequently affected. Growth of the neoplasm is usually slow, and clinical presen­tation is not usually specic. Appearance can present as par­onychia, onycholysis, hematoma, ulceration, or a nodule. Age of appearance can vary greatly, but subungual SCC most frequently appears in middle-aged Caucasian males [45]. Bowen’s disease is a very early form of SCC and is com­monly referred to as SCC in situ. Biopsy is the gold standard for diagnosis of subungual SCC. Treatment involves exci­sion of the lesion (Fig.1.29).
14
https://t.me/medicina_free
Fig. 1.29 SCC of great toenail bed
1.8.7 Subungual Melanoma
1 Nail Disorders oftheLower Extremity
Subungual melanoma is a neoplasm derived from malignant melanocytes that originate in the nail matrix. Classic pre­sentation is a dark pigmented band grown longitudinally through the nail unit and usually occurs on the great toe, thumb, or index nger. Subungual melanoma is proportion­ately the most common form of melanoma in dark-skinned individuals [46]. It initially presents as a longitudinal brown or black band through the nail unit. It is often misdiagnosed as a benign nail matrix nevus. As the melanoma evolves over weeks to months, the neoplasm can undergo changes such as larger width, irregular pigmentation, extension to the nail fold (Hutchinson’s sign), ulceration, formation of a nodule, and resultant nail destruction and dystrophy. In some cases, subungual melanoma is amelanotic and not pig­mented [47]. Subungual melanoma is not thought to be inuenced by UVA or UVB exposure. Exact pathogenesis is unknown, but it can be associated with nail bed trauma, weakened immune system, and familial history of mela­noma or other malignancies [48]. Treatment includes removal of affected nail and wide excision of the nail unit with adequate margins. Amputation may be necessary. Prognosis can be good but depends on depth and extent of invasion (Fig.1.30).
Fig. 1.30 Subungual melanoma of hallux that was misdiagnosed as a paronychia and pyogenic granuloma
References
1. Braswell MA, Daniel CR 3rd, Brodell RT.Beau lines, onychoma­desis, and retronychia: a unifying hypothesis. J Am Acad Dermatol. 2015;73(5):849–55.
2. Damevska K, Gocev G, Pollozahani N, Nikolovska S, Neloska L. Onychomadesis following cutaneous vasculitis. Acta Dermatovenerol Croat. 2015;25(1):77–9.
3. Baran R.The nail in dermatological disease. In: Baran & Dawber’s diseases of the nails and their management. Oxford, UK: Blackwell Publishing Ltd.; 2012. p.257–314.
4. Gordon K, Vega J, Tosti A.Trachyonychia: a comprehensive review. Indian J Dermatol Venereol Leprol. 2011;77(6):640–5.
5. Bodman MA. Nail dystrophies. Clin Podiatr Med Surg. 2004;21(4):663–87, viii
6. Taguchi Y, Takashima S, Tanaka K.Koilonychia in a patient with subacute iron-deciency anemia. Intern Med. 2013;52(20):2379.
7. Baran R, Haneke E, Richert B.Pincer nails: denition and surgical treatment. Dermatol Surg. 2001;27(3):261.
References
https://t.me/medicina_free
15
8. Fawcett RS, Linford S, Stulberg DL.Nail abnormalities: clues to systemic disease. Am Fam Physician. 2004;69(6):1417–24.
9. Maddy T. Hair and nail diseases in the mature patient. Clin Dermatol. 2018;36(2):159–66.
10. Canavan T, Tosti A, Mallory H, McKay K, Cantrell W, Elewski B. An idiopathic leukonychia totalis and leukonychia partia­lis case report and review of the literature. Skin Append Disord. 2015;1(1):38–42.
11. Sharma S, Gupta A, Deshmukh A, Puri V. Arsenic poisoning and Mees’ lines. QJM. 2016;109(8):565–6.
12. Chávez-López MA, Arce-Martínez FJ, Tello-Esparza A.Muehrcke lines associated to active rheumatoid arthritis. J Clin Rheumatol. 2013;19(1):30–1.
13. Maino KL, Stashower ME. Traumatic transverse leukonychia. Skinmed. 2004;3(1):53–5.
14. Salem A, Gamil H, Hamed M, Galal S.Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. 2010;24(6): 649–54.
15. Jefferson J, Rich P. Melanonychia. Dermatol Res Pract. 2012;2012:952186. https://doi.org/10.1155/2012/952186.
16. Metzner MJ, Billington AR, Payne WG. Melanonychia. Eplasty. 2015;15:ic48.
17. Chiriac A, Brzezinski P, Foia L, Marincu I. Chloronychia: Green Nail Syndrome Caused by Pseudomonas aeruginosa in elderly per­sons. Clin Interv Aging. 2015;10:265–7.
18. Rallis E, Paparizos V, Flemetakis A, Katsambas A.Pseudomonas ngernail infection successfully treated with topical nadi­oxacin in HIV-positive patients: report of two cases. AIDS. 2010;24(7):1087–8.
19. Matsuura H, Senoo A, Saito M, Hamanaka Y.Green nail syndrome. QJM An Intl J Med. 2017;110(9):609.
20. Baran R. Pigmentations of the nails (chromonychia). J Dermatol Surg Oncol. 1978;4:250–4.
21. Stosiek N, Peters KP, Hiller D, Riedl B, Hornstein OP. Yellow nail syndrome in a patient with mycosis fungoides. J Am Acad Dermatol. 1993;28:792–4.
22. Venencie PY, Dicken CH. Yellow nail syndrome: report of ve cases. J Am Acad Dermatol. 1984;10:187–92.
23. Daniel R, Meir B, Avner S. An update on the disappearing nail bed. Skin Append Disord. 2017;3(1):15–7. https://doi.
org/10.1159/000455013.
24. Malay S.Trauma to the nail bed and associated structures. Podiat Inst. 1993;1993:133.
25. Haneke E. Controversies in the treatment of ingrown nails. Dermatol Res Pract. 2012;2012:783924.
26. Domínguez-Cherit J, Lima-Galindo AA.Congenital malalignment of the great toenail: conservative and denitive treatment. Pediatr Dermatol. 2021;38(3):555–60. https://doi.org/10.1111/pde.14548.
27. Mello CDBF, etal. Ret onychia. An Bras Dermatol. 2018;93(5):707–
11. https://doi.org/10.1590/abd1806- 4841.20187908.
28. Thomas L, Azad J, Takwale A.Management of nail psoriasis. Clin Exp Dermatol. 2021;46(1):3–8. https://doi.org/10.1111/ced.14314.
29. Wechsuruk P, Bunyaratavej S, Kiratiwongwan R, Suphatsathienkul P, Wongdama S, Leeyaphan C.Clinical features and treatment out­comes of nail lichen planus: a retrospective study. JAAD Case Rep. 2021;22(17):43–8. https://doi.org/10.1016/j.jdcr.2021.09.015.
30. Iorizzo M, Tosti A, Starace M, Baran R, Daniel CR 3rd, Di Chiacchio N, Goettmann S, Grover C, Haneke E, Lipner SR, Rich P, Richert B, Rigopoulos D, Rubin AI, Zaiac M, Piraccini BM.Isolated nail lichen planus: an expert consensus on treatment of the classical form. J Am Acad Dermatol. 2020;83(6):1717–23.
https://doi.org/10.1016/j.jaad.2020.02.056.
31. Betz D, Fane K. Herpetic whitlow. [Updated 2021 Aug 6]. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing;
2022. Available from: https://www.ncbi.nlm.nih.gov/books/
NBK482379/
32. Collier E, Parikh P, Martin-Blais R, Chen J, Anand V. Herpetic whitlow of the toe presenting with severe viral cellulitis. Pediatr Dermatol. 2019;36(3):406–7. https://doi.org/10.1111/pde.13795.
33. Bae JM, Kang H, Kim HO, Park YM. Differential diagnosis of plantar wart from corn, callus and healed wart with the aid of der­moscopy. Br J Dermatol. 2009;160(1):220–2.
34. Lipner SR, Scher RK.Part I: onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2018;80(4):835–51.
35. Richert B, Lecerf P, Caucanas M, André J. Nail tumors. Clin Dermatol. 2013;31(5):602–17.
36. Abimelec P, Dumontier C. Basic and advanced nail surgery (Part 2: indications and complications). In: Scher RK, Daniel III RC, editors. Nails: diagnosis, therapy, and surgery. Elsevier Saunders;
2005. p.291.
37. Baran R, Perrin C, Baudet J, Requena L. Clinical and histologi­cal patterns of dermatobromas of the nail apparatus. Clin Exp Dermatol. 1994;l19(1):31–5.
38. Kojima T, Nagano T, Uchida M.Periungual broma. J Hand Surg Am. 1987;12(3):465–70.
39. Hernández-Lugo A, Domínguez-Cherit J, Vega-Memije M.Digital mucoid cyst: the ganglion type. Int J Dermatol. 1999;38(7):533–5.
40. Balakirski GM, Loeser C, Baron J, Dippel E, Schmitt L.Effectiveness and safety of surgical excision in the treatment of digital mucoid cysts. Dermatol Surg. 2017;43(7):928–33.
41. DaCambra MP, Gupta SK, Ferri-de-Barros F. Subungual exos­tosis of the toes: a systematic review. Clin Orthop Relat Res. 2018;472(4):1251–9.
42. Davis DA, Cohen PR.Subungual exostosis: case report and review of the literature. Pediatr Dermatol. 1996;13(3):212–8.
43. Letts M, Davidson D, Nizalik E.Subungual exostosis: diagnosis and treatment in children. J Trauma. 1998;44(2):346–9.
44. Lee JH, Lim Y, Park JH, Lee JH, Jang KT, Kwon EJ, Lee DY. Clinicopathologic features of 28 cases of nail matrix nevi (NMNs) in Asians: comparison between children and adults. J Am Acad Dermatol. 2018;78(3):479–89.
45. Sousa Padilha CB, Almeida Balassiano LK, Pinto JC, Souza FCS, Kac BK, Treu CM.Subungual squamous cell carcinoma. An Bras Dermatol. 2016;91(6):817–9.
46. Lee JH, Park J-H, Lee JH, Lee D-Y.Early detection of subungual melanoma in situ: proposal of ABCD strategy in clinical practice based on case series. Ann Dermatol. 2018;30(1):36–40.
47. Chamberlain A, Ng J.Cutaneous melanoma--atypical variants and presentations. Aust Fam Physician. 2009;38:476–82.
48. Singal A, Pandhi D, Gogoi P, Grover C.Subungual melanoma is not so rare: report of four cases from India. Indian Dermatol Online J. 2017;8(6):471–4.
Superficial Fungal Infections
https://t.me/medicina_free
oftheLower Extremity
Supercial fungal infections of the lower extremity may be caused by dermatophytes, yeast, and molds and may become secondarily infected with bacteria. Dermatophytes that pre­fer skin, hair, and nails are Trichophyton sp, Microsporum sp, and Epidermophyton sp. The most common pedal patho- gen is Trichophyton rubrum. Dermatophytes are contagious and may be transferred from soil, animals, fomites, and from other humans.
Wearing shoes, sneakers, and boots contributes to a warm and moist environment, an optimal milieu for fungi to thrive. These pedal infections, known as tinea pedis or athlete’s foot, generally occur in the interdigital areas where pro­longed moisture causes maceration, and on the plantar sur­face of the foot leading to dry, scaly, and itchy skin. Populations at risk include those who use communal facili­ties (pools, dorm showers, gyms); those who wear rubber or non-breathable shoes at work; and persons who are obese, diabetic, immunocompromised, vascularly compromised and are unable to perform regular foot hygiene [1].
KOH examination is useful to determine if a dry, scaly plantar rash is tinea pedis or xerosis. Tinea pedis is positive for the presence of fungal hyphae (Figs.2.1 and 2.2).
Tinea pedis can serve as a nidus of infection resulting in spread to other body sites. Common types of dermatophytosis are tinea corporis (body), tinea cruris (groin), tinea manuum (hands), tinea capitis (scalp), and onychomycosis (nails).
Tinea pedis can resemble other conditions including eczema, plaque and pustular psoriasis, allergic contact der­matitis, irritant contact dermatitis, dyshidrosis, xerosis, sec­ondary syphilis, erythrasma, pitted keratolysis, and soft corn (heloma molle).
2
Fig. 2.1 Plantar xerosis has scale within the skin lines and is KOH
negative
2.1 Interdigital Tinea Pedis
Interdigital tinea pedis is the most common form and is often located within the fourth interspace (between the fourth and fth toes) although all interspaces can be
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2022 T. C. Vlahovic, S. M. Schleicher, Atlas of Lower Extremity Skin Disease, https://doi.org/10.1007/978-3-031-07950-4_2
Fig. 2.2 Severe plantar xerosis
17
18
https://t.me/medicina_free
affected with spread plantarly to the toe sulcus. The condi­tion can present as a dry, pruritic, and scaly rash or as inamed, macerated tissue deep in the interspace which can ssure, ulcerate, and become secondarily infected with bacteria such as Corynebacterium or Pseudomonas, result­ing in localized cellulitis or lymphangitis (Figs. 2.3, 2.4, and 2.5).
2 Supercial Fungal Infections oftheLower Extremity
Fig. 2.3 Dry interdigital tinea pedis
Fig. 2.4 Macerated tissue in interdigital tinea pedis
Fig. 2.6 Moccasin tinea pedis
2.2 Moccasin Tinea Pedis
T. rubrum is the most common cause of this chronic form of tinea pedis that affects the plantar and lateral aspects of the foot in a moccasin shoe-type distribution [1]. Usually bilat­eral, it presents as serpiginous circular scale which may be erythematous and pruritic. Associated ndings can include ssures and onychomycosis (Fig.2.6).
2.3 Vesicular or Vesiculobullous Tinea Pedis
This condition presents as vesicles on a background of ery­thema localized to the dorsum of the foot and is possibly secondary to an autosensitization dermatitis triggered by dermatophytes. Lesions may be painful or pruritic. Differential diagnosis includes pustular psoriasis and bacte­rial infection (Fig.2.7) [1].
Fig. 2.5 Superinfected tinea pedis with inammation dorsally
2.4 Tinea Incognito
Tinea incognito results from a dermatophyte infection that has been inappropriately treated with topical steroids [2]. The condition may have initially been diagnosed as eczema
2.6 Tinea Nigra
https://t.me/medicina_free
Fig. 2.7 Vesicular tinea pedis
19
Fig. 2.8 Tinea incognito resulting from Class I topical steroid use on a tinea pedis infection
or psoriasis. Pruritus, scaling, and erythema improve at onset but over time the infection extends. A nondescript macular rash evolves into a circinate patch with raised borders and at times scattered vesicles. KOH (potassium hydroxide) prepa­ration reveals numerous fungal elements. Treatment entails discontinuation of topical steroids and institution of antifun­gal therapy (Fig.2.8).
2.5 Majocchi’s Granuloma
Majocchi’s granuloma, also referred to as granuloma tricho­phyticum, is a suppurative and granulomatous folliculitis caused by a fungal infection. In most cases the causal agent is Trichophyton rubrum [3]. The condition often occurs in association with tinea unguium and tinea pedis. In women, Majocchi’s granuloma may be precipitated by shaving and
Fig. 2.9 Majocchi’s granuloma on the leg
waxing. Cases have been related to both topical steroid use and immunosuppression. When associated with the latter common ndings include indurated plaques with erythema­tous subcutaneous nodules [4].
Conrmation of Majocchi’s granuloma is best achieved by fungal culture and/or biopsy. Because the infection is deep-seated within hair follicles topical antifungals are inef­fectual. Therapeutic options include terbinane and itracon­azole (Fig.2.9) [4].
2.6 Tinea Nigra
Tinea nigra is a supercial fungal infection caused by Hortaea werneckii. Predominantly found in tropical and sub­tropical locales, it can be seen in persons returning from endemic areas [5]. The disorder presents as a well-dened, asymptomatic, brown-black hyperpigmented macule or patch without scale on the hands and feet and may be misdi­agnosed as an acral nevus or melanoma. KOH and fungal culture are positive and the condition responds well to topi­cal antifungals (Fig.2.10).
20
https://t.me/medicina_free
Fig. 2.10 Tinea nigra on the nail unit that was misdiagnosed as acral melanoma
2 Supercial Fungal Infections oftheLower Extremity
areas. Patients can also use ultraviolet shoe sanitizers to decrease the bioburden in daily shoe gear.
Often the patient will self-treat with over-the-counter preparations that consist of medicated foot powders, sprays, and creams such as Castellani’s paint, gentian violet, undec­ylenic acid, miconazole, clotrimazole, tolnaftate, butenane, and terbinane. Prescription antifungal topical preparations include the following:
• Ciclopirox
• Econazole
• Ketoconazole
• Luliconazole
• Naftine
• Oxiconazole
• Sertaconazole
Longstanding or severe infections may warrant an oral antifungal. Approved medications are griseofulvin, terbin­ane, itraconazole, and uconazole. In addition to a topical antifungal, the clinician may add a keratolytic to descale the plantar skin and decrease transepidermal water loss. Lactic acid, salicylic acid, and urea preparations may facilitate ef­cacy of the antifungal.
Bacterial superinfection may require topical and/or oral antibiotics for adequate control. Topical preparations that decrease sweating such as aluminum chloride solution and powders, as well as botulinum toxin injection, may help pre­vent recurrence.
2.7 Laboratory Tests
A supercial fungal infection is often suspected based on history and examination. Various laboratory tests may be used to conrm the diagnosis such as KOH examination, fungal culture, periodic acid Schiff (PAS) stain, and poly­merase chain reaction (PCR). A punch biopsy may be useful to differentiate tinea from an inammatory skin disorder like psoriasis.
When sampling a dermatitis for KOH or culture, scraping of the leading edge with a No. 15 blade provides the highest yield. Cultures should be observed for up to 4weeks due to the slow growth of dermatophytes.
2.8 Treatment
Patients should be educated on foot hygiene: drying between toes, changing socks and shoes daily, disinfecting family showering areas, and wearing shower shoes in communal
References
1. Nigam PK, Saleh D. Tinea Pedis. [2021 Jun 7]. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2022.
2. Nowowiejska J, Baran A, Flisiak I.Tinea incognito: a great physi­cian pitfall. J Fungi (Basel). 2022;8(3):312. https://doi.org/10.3390/
jof8030312.
3. Boral H, Durdu M, Ilkit M.Majocchi’s granuloma: current perspec­tives. Infect Drug Resist. 2018;11:751–60. https://doi.org/10.2147/
IDR.S145027.
4. Castellanos J, Guillén-Flórez A, Valencia-Herrera A, etal. Unusual inammatory tinea infections: Majocchi’s granuloma and deep/sys­temic dermatophytosis. J Fungi (Basel). 2021;7(11):929. https://doi.
org/10.3390/jof7110929.
5. Eksomtramage T, Aiempanakit K. Tinea nigra mimicking acral melanocytic nevi. IDCases. 2019;18:e00654. https://doi.
org/10.1016/j.idcr.2019.e00654.